Tacrolimus for the management of psoriasis: clinical utility and place in therapy

References

• GriffithsCEBarkerJNPathogenesis and clinical features of psoriasisLancet2007370958326327117658397
   PubMed Web of Science ®Google Scholar
• CoimbraSFigueiredoACastroERocha-PereiraPSantos-SilvaAThe roles of cells and cytokines in the pathogenesis of psoriasisInt J Dermatol2012514389395 quiz 95–9822435425
   PubMed Web of Science ®Google Scholar
• HebertHLAliFRBowesJGriffithsCEBartonAWarrenRBGenetic susceptibility to psoriasis and psoriatic arthritis: implications for therapyBr J Dermatol2012166347448222050552
   PubMed Web of Science ®Google Scholar
• BarkerJNThe pathophysiology of psoriasisLancet199133887612272301676787
   PubMed Web of Science ®Google Scholar
• ChristophersEPsoriasis – epidemiology and clinical spectrumClin Exp Dermatol200126431432011422182
   PubMed Web of Science ®Google Scholar
• LawsPMYoungHSTopical treatment of psoriasisExpert Opin Pharmacother201011121999200920569091
   PubMed Web of Science ®Google Scholar
• AlbrechtLBourcierMAshkenasJTopical psoriasis therapy in the age of biologics: evidence-based treatment recommendationsJ Cutan Med Surg201115630932122202506
   PubMed Web of Science ®Google Scholar
• LemsterBHCarrollPBRiloHRJohnsonNNikaeinAThomsonAWIL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapyClin Exp Immunol19959921481547531627
   PubMed Web of Science ®Google Scholar
• ZonneveldIMRubinsAJablonskaSTopical tacrolimus is not effective in chronic plaque psoriasis. A pilot studyArch Dermatol19981349110111029762021
   PubMed Web of Science ®Google Scholar
• CarrollCLClarkeJCamachoFBalkrishnanRFeldmanSRTopical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatmentArch Dermatol20051411434615655140
   PubMedGoogle Scholar
• OrtonneJPvan de KerkhofPCPrinzJC0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: results of a randomized, open-label, observer-blinded studyActa Derm Venereol2006861293316585986
   PubMed Web of Science ®Google Scholar
• MaloneyJMFloresJSheehanMSchlessingerJEfficacy and safety of 0.1% and 0.5% tacrolimus cream versus vehicle for treatment of mild to moderate plaque psoriasis in adultsJ Am Acad Dermatol2007562, Suppl 2AB10
   Google Scholar
• VissersWHvan VlijmenIvan ErpPEde JongEMvan de KerkhofPCTopical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expressionBr J Dermatol2008158470571218284400
   PubMed Web of Science ®Google Scholar
• OmlandSHGniadeckiRPsoriasis inversa: a separate identity or a variant of psoriasis vulgaris?Clin Dermatol201533445646126051061
   PubMed Web of Science ®Google Scholar
• RemitzAReitamoSErkkoPGranlundHLauermaAITacrolimus ointment improves psoriasis in a microplaque assayBr J Dermatol1999141110310710417522
   PubMed Web of Science ®Google Scholar
• YamamotoTNishiokaKTopical tacrolimus is effective for facial lesions of psoriasisActa Derm Venereol200080645111243645
   PubMed Web of Science ®Google Scholar
• YamamotoTNishiokaKTopical tacrolimus: an effective therapy for facial psoriasisEur J Dermatol200313547147314693492
   PubMed Web of Science ®Google Scholar
• ClaytonTHHarrisonPVNichollsRDelapMTopical tacrolimus for facial psoriasisBr J Dermatol2003149241942012932257
   PubMed Web of Science ®Google Scholar
• KroftEBErcegAMaimetsKVissersWvan der ValkPGvan de KerkhofPCTacrolimus ointment for the treatment of severe facial plaque psoriasisJ Eur Acad Dermatol Venereol200519224925115752305
   PubMed Web of Science ®Google Scholar
• RallisENasiopoulouAKouskoukisCSuccessful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%Drugs Exp Clin Res200531414114516223203
   PubMedGoogle Scholar
• LebwohlMFreemanAKChapmanMSFeldmanSRHartleJEHenningATacrolimus ointment is effective for facial and intertriginous psoriasisJ Am Acad Dermatol200451572373015523350
   PubMed Web of Science ®Google Scholar
• FreemanAKLinowskiGJBradyCTacrolimus ointment for the treatment of psoriasis on the face and intertriginous areasJ Am Acad Dermatol200348456456812664020
   PubMed Web of Science ®Google Scholar
• LiaoYHChiuHCTsengYSTsaiTFComparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(−1) ointment and tacrolimus 0.3 mg g(−1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trialBr J Dermatol200715751005101217935517
   PubMed Web of Science ®Google Scholar
• Martin EzquerraGSanchez ReganaMHerrera AcostaEUmbert MilletPTopical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaquesJ Drugs Dermatol20065433433616673800
   PubMedGoogle Scholar
• BissonnetteRNigenSBolducCEfficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasisJ Cutan Med Surg200812523023418845092
   PubMed Web of Science ®Google Scholar
• SteeleJAChoiCKwongPCTopical tacrolimus in the treatment of inverse psoriasis in childrenJ Am Acad Dermatol200553471371616198804
   PubMed Web of Science ®Google Scholar
• BruneAMillerDWLinPCotrim-RussiDPallerASTacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patientsPediatric Dermatol20072417680
   PubMed Web of Science ®Google Scholar
• De SimoneCMaiorinoATassoneFD’AgostinoMCaldarolaGTacrolimus 0.1% ointment in nail psoriasis: a randomized controlled open-label studyJ Eur Acad Dermatol Venereol20132781003100622788697
   PubMed Web of Science ®Google Scholar
• NagaoKIshikoAYokoyamaTTanikawaAAmagaiMA case of generalized pustular psoriasis treated with topical tacrolimusArch Dermatol200313991219
   Google Scholar
• Rodriguez GarciaFFagundo GonzalezECabrera-PazRGeneralized pustular psoriasis successfully treated with topical tacrolimusBr J Dermatol2005152358758815787845
   PubMed Web of Science ®Google Scholar
• LainoLDiCarloAPalmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatmentArch Dermatol2011147676021690553
   PubMedGoogle Scholar
• YamamotoTNishiokaKSuccessful treatment with topical tacrolimus for oral psoriasisJ Eur Acad Dermatol Venereol20062091137113816987275
   PubMed Web of Science ®Google Scholar
• SehgalVNSehgalSVermaPSinghNRasoolFExclusive plaque psoriasis of the lips: efficacy of combination therapy of topical tacrolimus, calcipotriol, and betamethasone dipropionateSkinmed201210318318422779103
   PubMedGoogle Scholar
• CarrascosaJMSoriaXDomingoHFerrandizCTreatment of inverse psoriasis with excimer therapy and tacrolimus ointmentDermatol Surg200733336136317338698
   PubMed Web of Science ®Google Scholar
• NikolaidisNLAbu-ElmagdKThomsonAWMetabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven casesTranspl Proc199123633253327
   Web of Science ®Google Scholar
• JegasothyBVAckermanCDTodoSFungJJAbu-ElmagdKStarzlTETacrolimus (FK 506) – a new therapeutic agent for severe recalcitrant psoriasisArch Dermatol199212867817851376102
   PubMedGoogle Scholar
• Group TEFMPSSystemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled studyArch Dermatol199613244194238629845
   PubMedGoogle Scholar
• WeiKCLaiPCCombination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasisDermatol Ther2015281252725285355
   PubMed Web of Science ®Google Scholar
• MittalADograSNarangTSharmaAPilot study to evaluate the efficacy and safety of oral tacrolimus in adult patients with refractory severe plaque psoriasisJ Cutan Med Surg201620322823226553734
   PubMed Web of Science ®Google Scholar
• KaltwasserJPNashPGladmanDEfficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trialArthritis Rheum20045061939195015188371
   PubMed Web of Science ®Google Scholar
• YocumDEFurstDEKaineJLEfficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trialArthritis Rheum200348123328333714673984
   PubMed Web of Science ®Google Scholar
• MortonSJPowellRJCyclosporin and tacrolimus: their use in a routine clinical setting for sclerodermaRheumatology200039886586910952740
   PubMed Web of Science ®Google Scholar
• YoonKHSuccessful usage of tacrolimus (FK506) in resistant/relapsed rheumatic diseasesAPLAR J Rheumatol2004714448
   Google Scholar
• LythgoeMAbrahamSTacrolimus: an effective treatment in refractory psoriatic arthritis following biologic failureClin Exp Rheumatol2016341 Suppl 95S12S13
   Web of Science ®Google Scholar
• AzziJRSayeghMHMallatSGCalcineurin inhibitors: 40 years later, can’t live withoutJ Immunol2013191125785579124319282
   PubMed Web of Science ®Google Scholar
• ShahSSHafeezFComparison of efficacy of tacrolimus versus cyclosporine in childhood steroid-resistant nephrotic syndromeJ Coll Physicians Surg Pak201626758959327504551
   PubMed Web of Science ®Google Scholar
• WeidemannAKCrawshawAAByrneEYoungHSVascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisClin Cosmet Investig Dermatol20136233244
   PubMedGoogle Scholar
• Tirado-SanchezAPonce-OliveraRMPreliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasisCutis201290314014423094314
   PubMed Web of Science ®Google Scholar
• BuderKKnuschkePWozelGEvaluation of methylprednisolone aceponate, tacrolimus and combination thereof in the psoriasis plaque test using sum score, 20-MHz-ultrasonography and optical coherence tomographyInt J Clin Pharmacol Ther2010481281482021084037
   PubMed Web of Science ®Google Scholar
• RivardJJanigaJLimHWTacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasisJ Drugs Dermatol20065650551016774101
   PubMedGoogle Scholar
• KleynCEWoodcockDSharpeGRThe efficacy of 0.1% tacrolimus ointment compared with clobetasone butyrate 0.05% ointment in patients with facial, flexural or genital psoriasisBr J Dermatol200515333
   Web of Science ®Google Scholar
• RajzerLWojas-PelcAObtulowiczAThe efficacy and safety of an ointment containing 0.1% tacrolimus in facial and flexural psoriasisJ Eur Acad Dermatol200519178
   Web of Science ®Google Scholar
• NelsonAKrejci-ManwaringJFleischerAA randomized, double-blind, vehicle-controlled, right/left comparative study of the efficacy of actitretin with and without the co-administration of 0.1% tacrolimus topical ointment in the treatment of moderate to severe psoriasisJ Am Acad Dermatol200756AB181
   Web of Science ®Google Scholar
• HeYClinical efficacy of 0.1% tacrolimus ointment on plaque psoriasis of scalp and faceJ Clin Dermatol200837254255
   Google Scholar